Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Giacomo Coltro, Terra L. Lasho, Christy M. Finke, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi, Dragan Jevremovic, Jessica K. Altman, Mrinal M. Patnaik*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)E231-E234
JournalAmerican Journal of Hematology
Volume94
Issue number9
DOIs
StatePublished - Sep 2019

Funding

Informed consent from the patient was obtained to share relevant data as outlined in the manuscript, including genetic information. Current publication is supported in part by grants from the “The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA.” This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

ASJC Scopus subject areas

  • Hematology

Cite this